Pasithea Therapeutics Corp.
KTTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5,448 | $4,069 | $1,425 | $3,453 |
| - Cash | $4,122,953 | $7,217 | $5,341 | $6,923 |
| + Debt | $0 | $155 | $269 | $0 |
| Enterprise Value | -$4,117,505 | -$2,993 | -$3,647 | -$3,470 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$182 | $0 | $0 | -$162 |
| % Margin | – | – | – | – |
| EBITDA | -$2,856 | -$3,649 | -$3,518 | -$3,015 |
| % Margin | – | – | – | – |
| Net Income | -$3,037 | -$3,716 | -$3,563 | -$3,178 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.41 | -0.66 | -3.25 | -2.9 |
| % Growth | 37.9% | 79.7% | -12.1% | – |
| Operating Cash Flow | -$2,890 | -$3,869 | -$3,056 | -$2,443 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$2,890 | -$3,869 | -$3,056 | -$2,443 |